Clinical trial
Treatment of the Acute Myeloblastic Leukaemia in Patients Over 65 Years
NCT00464217 · PETHEMA Foundation, Other · Completed
Key facts
| NCT number | NCT00464217 |
|---|---|
| Title | Treatment of the Acute Myeloblastic Leukaemia in Patients Over 65 Years |
| Official title | PETHEMA-LAM99:Treatment of the Acute Myeloblastic Leukaemia in Patients Over 65 Years |
| Lead sponsor | PETHEMA Foundation, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Acute Myeloblastic Leukaemia |
| Intervention type | Drug |
| Interventions | ARA-C, Idarubicin, Leucomax |
| Enrollment | 100 |
| Start date | Oct 1, 1998 |
| Primary completion | Dec 1, 2008 |
| Completion | Dec 1, 2008 |
| First posted | Apr 23, 2007 |
| Last update posted | Jan 5, 2010 |
| Countries | Spain |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: